RespireRx Pharmaceuticals Probability of Future Pink Sheet Price Finishing Under 0.00527
| RSPIDelisted Stock | USD 0.01 0.00 0.00% |
RespireRx |
RespireRx Pharmaceuticals Target Price Odds to finish below 0.00527
The tendency of RespireRx Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.01 or more in 90 days |
| 0.01 | 90 days | 0.01 | about 71.23 |
Based on a normal probability distribution, the odds of RespireRx Pharmaceuticals to drop to $ 0.01 or more in 90 days from now is about 71.23 (This RespireRx Pharmaceuticals probability density function shows the probability of RespireRx Pink Sheet to fall within a particular range of prices over 90 days) . Probability of RespireRx Pharmaceuticals price to stay between $ 0.01 and its current price of $0.007 at the end of the 90-day period is about 25.79 .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 6.2 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, RespireRx Pharmaceuticals will likely underperform. Additionally RespireRx Pharmaceuticals has an alpha of 0.8371, implying that it can generate a 0.84 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). RespireRx Pharmaceuticals Price Density |
| Price |
Predictive Modules for RespireRx Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as RespireRx Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.RespireRx Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. RespireRx Pharmaceuticals is not an exception. The market had few large corrections towards the RespireRx Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold RespireRx Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of RespireRx Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.84 | |
β | Beta against Dow Jones | 6.20 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.08 |
RespireRx Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RespireRx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RespireRx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RespireRx Pharmaceuticals is not yet fully synchronised with the market data | |
| RespireRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| RespireRx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| RespireRx Pharmaceuticals currently holds 2.42 M in liabilities. RespireRx Pharmaceuticals has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist RespireRx Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, RespireRx Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RespireRx Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RespireRx to invest in growth at high rates of return. When we think about RespireRx Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RespireRx Pharmaceuticals currently holds about 21 in cash with (956.17 K) of positive cash flow from operations. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
RespireRx Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of RespireRx Pink Sheet often depends not only on the future outlook of the current and potential RespireRx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. RespireRx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 88.3 M | |
| Cash And Short Term Investments | 1398.00 |
RespireRx Pharmaceuticals Technical Analysis
RespireRx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. RespireRx Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of RespireRx Pharmaceuticals. In general, you should focus on analyzing RespireRx Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
RespireRx Pharmaceuticals Predictive Forecast Models
RespireRx Pharmaceuticals' time-series forecasting models is one of many RespireRx Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary RespireRx Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about RespireRx Pharmaceuticals
Checking the ongoing alerts about RespireRx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for RespireRx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| RespireRx Pharmaceuticals is not yet fully synchronised with the market data | |
| RespireRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| RespireRx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| RespireRx Pharmaceuticals currently holds 2.42 M in liabilities. RespireRx Pharmaceuticals has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist RespireRx Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, RespireRx Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RespireRx Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RespireRx to invest in growth at high rates of return. When we think about RespireRx Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RespireRx Pharmaceuticals currently holds about 21 in cash with (956.17 K) of positive cash flow from operations. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in RespireRx Pink Sheet
If you are still planning to invest in RespireRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RespireRx Pharmaceuticals' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |